Public Health Wales
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith
BROOKLYN, NCT05425745 / 2021-005064-22: Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

Completed
3
354
Europe, Canada, US, RoW
Obicetrapib, CETP-inhibitor, Placebo
NewAmsterdam Pharma
Dyslipidemias, High Cholesterol, Hypercholesterolemia, Familial Hypercholesterolemia, Lipid Metabolism Disorder, Metabolic Disease, Lipid Metabolism, Inborn Errors, Genetic Disease, Inborn, Hyperlipoproteinemias
05/24
05/24
NCT04505436: Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Active, not recruiting
2
215
US, RoW
HM15211, efocipegtrutide, Placebo of HM15211
Hanmi Pharmaceutical Company Limited
NASH - Nonalcoholic Steatohepatitis
06/26
07/26
NalPORS, NCT05072249: European Cohort Study of the Effectiveness of Take Home Naloxone

Recruiting
N/A
6000
Europe
Naloxone, Prenoxad, Nyxoid, Ventizolve
King's College London, Mundipharma Research Limited
Opioid Overdose
12/23
12/23
Healy, Brendan
No trials found
Adamson, James
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith
BROOKLYN, NCT05425745 / 2021-005064-22: Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

Completed
3
354
Europe, Canada, US, RoW
Obicetrapib, CETP-inhibitor, Placebo
NewAmsterdam Pharma
Dyslipidemias, High Cholesterol, Hypercholesterolemia, Familial Hypercholesterolemia, Lipid Metabolism Disorder, Metabolic Disease, Lipid Metabolism, Inborn Errors, Genetic Disease, Inborn, Hyperlipoproteinemias
05/24
05/24
NCT04505436: Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Active, not recruiting
2
215
US, RoW
HM15211, efocipegtrutide, Placebo of HM15211
Hanmi Pharmaceutical Company Limited
NASH - Nonalcoholic Steatohepatitis
06/26
07/26
NalPORS, NCT05072249: European Cohort Study of the Effectiveness of Take Home Naloxone

Recruiting
N/A
6000
Europe
Naloxone, Prenoxad, Nyxoid, Ventizolve
King's College London, Mundipharma Research Limited
Opioid Overdose
12/23
12/23
Healy, Brendan
No trials found
Adamson, James
No trials found

Download Options